Illumina, Inc.

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Targets set

SBTI ID

40001278

Informations générales

Localisation

United States of America

Northern America

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

30/06/2022

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Objectifs à long terme (Long-Term)
Engagement de réduction des émissions à horizon 2050

Statut

Targets set

Classification

1.5°C

Année cible

2050

Progression vers l'objectif31%
2015 (année de référence)2050
Description complète des objectifs

Overall Net-Zero Target Illumina, Inc. commits to reach net zero greenhouse gas emissions across direct operations and the value chain by 2050 from a 2019 base year. Near-Term Targets Illumina, Inc. commits to reduce absolute scope 1 and 2 GHG emissions 46% by 2030 from a 2019 base year. Illumina, Inc. also commits to increase annual sourcing of renewable electricity from 0.6% in 2019 to 100% by 2030. Illumina, Inc. further commits to reduce absolute scope 3 GHG emissions from purchased goods and services, capital goods, upstream transportation and distribution, business travel, employee commuting and investments 46% by 2030 from a 2019 base year. Long-Term Targets Illumina, Inc. commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2050 from a 2019 base year. Illumina, Inc. commits to reduce absolute scope 3 emissions from purchased goods and services, capital goods, upstream transportation and distribution, business travel, employee commuting and investments 90% by 2050 from a 2019 base year.

Net-Zero

Statut

Targets set

Année cible

2050

Progression31%
Business Ambition 1.5°C

Statut

BA1.5 member

Date d'engagement

12/08/2021

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

US4523271090

LEI

SQ95QG8SR5Q56LSNF682

Source : Science Based Targets initiative | Données publiques